Quality of Life and Self-care in Patients With Diabetic Foot Ulcers Treated With Low-level Laser Therapy
Diabetic Foot Ulcer, Diabetic Foot
About this trial
This is an interventional treatment trial for Diabetic Foot Ulcer
Eligibility Criteria
Inclusion Criteria:
- Type 2 diabetes mellitus patients with diabetic foot ulcers;
- Patients aged 18 to 79 years.
Exclusion Criteria:
- Presence of autoimmune disease;
- Presence of psychiatric or cognitive disorders that impede the application of questionnaires;
- Pressure ulcers
- Venous ulcers;
- Contraindications to the treatment methods adopted in the research;
- Ulcers in other parts of the body than the feet;
- Diabetic foot ulcers infected.
Sites / Locations
- Federal University of PiauiRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Placebo Comparator
Active Comparator
Active Comparator
Active Comparator
CG (control group) + dressing
LG1 (LLLT group 1) + dressing
LG2 (LLLT group 2) + dressing
LG3 (LLLT group 3) + dressing
The group will receive placebo LLLT (low-level laser therapy) application associated with Helianthus annuus oil dressing.
The group will receive application of LLLT (low-level laser therapy) Gallium Arsenide (GaAs) 904 nm 10 J/cm² associated with Helianthus annuus oil dressing.
The group will receive application of LLLT (low-level laser therapy) Gallium Arsenide (GaAs) 904 nm 8 J/cm² associated with Helianthus annuus oil dressing.
The group will receive application of LLLT (low-level laser therapy) Gallium Arsenide (GaAs) 904 nm 4 J/cm² associated with Helianthus annuus oil dressing.